Free Trial

Cardlytics (CDLX) Competitors

$8.72
-0.52 (-5.63%)
(As of 06/7/2024 ET)

CDLX vs. EB, HCAT, VNET, SVMK, GRND, GDS, BMBL, IAS, SABR, and MODN

Should you be buying Cardlytics stock or one of its competitors? The main competitors of Cardlytics include Eventbrite (EB), Health Catalyst (HCAT), VNET Group (VNET), SVMK (SVMK), Grindr (GRND), GDS (GDS), Bumble (BMBL), Integral Ad Science (IAS), Sabre (SABR), and Model N (MODN).

Cardlytics vs.

Cardlytics (NASDAQ:CDLX) and Eventbrite (NYSE:EB) are both small-cap business services companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, earnings, media sentiment, dividends, analyst recommendations, institutional ownership, community ranking, valuation and profitability.

Cardlytics received 52 more outperform votes than Eventbrite when rated by MarketBeat users. Likewise, 58.20% of users gave Cardlytics an outperform vote while only 57.34% of users gave Eventbrite an outperform vote.

CompanyUnderperformOutperform
CardlyticsOutperform Votes
220
58.20%
Underperform Votes
158
41.80%
EventbriteOutperform Votes
168
57.34%
Underperform Votes
125
42.66%

Eventbrite has a net margin of -5.47% compared to Cardlytics' net margin of -55.23%. Eventbrite's return on equity of -10.00% beat Cardlytics' return on equity.

Company Net Margins Return on Equity Return on Assets
Cardlytics-55.23% -25.36% -8.37%
Eventbrite -5.47%-10.00%-1.95%

Cardlytics has a beta of 1.67, meaning that its stock price is 67% more volatile than the S&P 500. Comparatively, Eventbrite has a beta of 2.32, meaning that its stock price is 132% more volatile than the S&P 500.

In the previous week, Cardlytics had 4 more articles in the media than Eventbrite. MarketBeat recorded 5 mentions for Cardlytics and 1 mentions for Eventbrite. Cardlytics' average media sentiment score of 0.85 beat Eventbrite's score of 0.00 indicating that Cardlytics is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Cardlytics
3 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Eventbrite
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

68.1% of Cardlytics shares are owned by institutional investors. Comparatively, 91.6% of Eventbrite shares are owned by institutional investors. 4.4% of Cardlytics shares are owned by insiders. Comparatively, 21.5% of Eventbrite shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Cardlytics currently has a consensus price target of $12.75, indicating a potential upside of 46.22%. Eventbrite has a consensus price target of $9.93, indicating a potential upside of 93.35%. Given Eventbrite's higher possible upside, analysts plainly believe Eventbrite is more favorable than Cardlytics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cardlytics
0 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.75
Eventbrite
0 Sell rating(s)
2 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.71

Eventbrite has higher revenue and earnings than Cardlytics. Eventbrite is trading at a lower price-to-earnings ratio than Cardlytics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cardlytics$309.20M1.38-$134.70M-$4.42-1.97
Eventbrite$334.47M1.49-$26.48M-$0.19-27.03

Summary

Eventbrite beats Cardlytics on 12 of the 18 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CDLX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CDLX vs. The Competition

MetricCardlyticsComputer & Data IndustryBusiness SectorNASDAQ Exchange
Market Cap$425.36M$75.36B$6.57B$8.17B
Dividend YieldN/A0.61%2.83%4.04%
P/E Ratio-1.9759.6738.1118.17
Price / Sales1.382,100.331,253.1077.69
Price / Cash7.7629.7123.7130.80
Price / Book2.544.024.584.33
Net Income-$134.70M$2.44B$120.81M$216.21M
7 Day Performance-0.46%0.21%-0.85%-1.43%
1 Month Performance-40.27%0.20%-1.42%-0.59%
1 Year Performance62.69%11.10%1.74%3.58%

Cardlytics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
EB
Eventbrite
4.0335 of 5 stars
$5.03
+3.3%
$9.93
+97.4%
-36.1%$488.46M$326.13M-26.47866News Coverage
Positive News
HCAT
Health Catalyst
4.3644 of 5 stars
$6.66
+0.5%
$12.18
+82.9%
-45.5%$393.14M$295.94M-3.601,300Analyst Forecast
VNET
VNET Group
1.8679 of 5 stars
$2.25
+2.7%
$2.85
+26.7%
-25.1%$579.15M$1.04B-0.853,038Gap Down
SVMK
SVMK
0 of 5 stars
N/AN/AN/A$1.38B$375.61M-14.541,367High Trading Volume
GRND
Grindr
1.6241 of 5 stars
$9.19
-1.6%
$13.33
+45.1%
+58.0%$1.61B$279.23M-51.05112Positive News
GDS
GDS
1.1824 of 5 stars
$8.42
+1.3%
$12.58
+49.4%
-23.5%$1.60B$1.40B-2.622,345Gap Down
BMBL
Bumble
4.5151 of 5 stars
$11.77
-0.3%
$15.89
+35.0%
-35.3%$1.49B$1.05B69.241,200Positive News
IAS
Integral Ad Science
3.6028 of 5 stars
$9.21
+0.7%
$16.77
+82.1%
-49.7%$1.48B$482.81M921.92880
SABR
Sabre
2.5691 of 5 stars
$3.10
+1.6%
$4.13
+33.1%
-18.6%$1.18B$2.91B-2.146,232Positive News
Gap Down
MODN
Model N
2.8903 of 5 stars
$29.92
+0.2%
$31.80
+6.3%
-9.2%$1.18B$249.46M-2,992,000.001,089Analyst Forecast

Related Companies and Tools

This page (NASDAQ:CDLX) was last updated on 6/8/2024 by MarketBeat.com Staff

From Our Partners